Mercer Global Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

Mercer Global Advisors’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$84.5K	Buy	+1,021	New	+$81.9K	﹤0.01%	3961

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Mercer Global Advisors's ANIP Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in ANI Pharmaceuticals (ANIP) in Q2 2026: 1,021 shares worth $84.5K. The stake represents ﹤0.01% of the portfolio and ranks #3961 among its holdings.

283 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

Mercer Global Advisors held 1,021 shares of ANI Pharmaceuticals worth $84.5K as of Q2 2026.
ANI Pharmaceuticals was a new Mercer Global Advisors position in Q2 2026.
ANI Pharmaceuticals made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3961 holding.
283 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.